HCA Healthcare, Inc.
General ticker "HCA" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $89.5B (TTM average)
HCA Healthcare, Inc. follows the US Stock Market performance with the rate: 50.1%.
Estimated limits based on current volatility of 1.6%: low 482.69$, high 497.93$
Factors to consider:
- Earnings expected soon, date: 2026-04-24 bmo
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-03-17, amount 0.78$ (Y0.64%)
- Total employees count: 316000 as of 2024
- Top business risk factors: Liquidity and credit risks, Cash flow risks, Regulatory and compliance, Labor/talent shortage/retention, Reimbursement risks
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [289.85$, 416.74$]
- 2025-12-31 to 2026-12-31 estimated range: [329.49$, 464.94$]
Financial Metrics affecting the HCA estimates:
- Negative: with PPE of 13.3 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 13.46 > 12.96
- Positive: 7.68 < Operating profit margin, % of 14.94
- Positive: -8.75 < Industry operating profit margin (median), % of -2.46
- Negative: Shareholder equity ratio, % of -4.20 <= 19.49
- Negative: Investing cash flow per share per price, % of -6.32 <= -4.45
- Positive: Return on assets ratio (scaled to [-100,100]) of 10.06 > 6.12
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 3.28
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term HCA quotes
Long-term HCA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $60,233.00MM | $64,968.00MM | $70,603.00MM |
| Operating Expenses | $51,180.00MM | $55,341.00MM | $60,056.00MM |
| Operating Income | $9,053.00MM | $9,627.00MM | $10,547.00MM |
| Non-Operating Income | $-473.00MM | $-1,921.00MM | $-2,024.00MM |
| Interest Expense | $1,739.00MM | $1,938.00MM | $2,061.00MM |
| Income(Loss) | $8,580.00MM | $7,706.00MM | $8,523.00MM |
| Taxes | $1,746.00MM | $1,615.00MM | $1,866.00MM |
| Profit(Loss)* | $5,643.00MM | $5,242.00MM | $5,760.00MM |
| Stockholders Equity | $-2,767.00MM | $-1,774.00MM | $-2,499.00MM |
| Inventory | $2,068.00MM | $2,021.00MM | $1,738.00MM |
| Assets | $52,438.00MM | $56,211.00MM | $59,513.00MM |
| Operating Cash Flow | $8,522.00MM | $9,431.00MM | $10,514.00MM |
| Capital expenditure | $4,395.00MM | $4,744.00MM | $4,875.00MM |
| Investing Cash Flow | $-3,389.00MM | $-5,317.00MM | $-4,933.00MM |
| Financing Cash Flow | $-5,656.00MM | $-4,094.00MM | $-4,582.00MM |
| Earnings Per Share** | $19.44 | $19.24 | $22.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.